ArticleCurrent issues in molecular biology2024

Frequency of Deleterious Germline Variants in HER2-Low Breast Cancer Patients Using a Hereditary Multipanel Gene Testing.

Janaina Pontes Batista Cassoli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.